Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Yes, they got some good results from biopsy less t

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155333
(Total Views: 528)
Posted On: 07/13/2019 6:20:57 AM
Avatar
Posted By: trding
Re: plavac #4821
Yes, they got some good results from biopsy less than 2 weeks in, see Fig 5D. We could get good results as early as 21 days in, seeing the ctc go below 5 is all it would take to convince me (and I'm sure some other shareholders). The 84 day estimate was the earliest estimate to convince the FDA to apply for breakthrough designation.

Quote:
Patients received 300 mg of maraviroc twice daily with a pre-treatment biopsy and a second biopsy of the same liver metastasis after treatment for 8–10 days (Figure 5A). Observed clinical effects include induction of central tumor necrosis (Figure 5B) and a partial remission of lung metastases (Figures 5C and S5A) In a patient with malignant pleural effusions, the reduction of MIF and hepatocyte growth factor (HGF) seen in the explant models was recapitulated within the effusion (Figure S5B), highlighting the systemic effects of maraviroc. On a histological level, all tumor samples showed reduced proliferation (as evidenced by Ki67 staining, Figure S5C) and increased tumor cell death as evidenced by morphology (Figure 5D), while the morphology of the adjacent normal liver was unchanged (Figure 5D). Moreover, the effects on the microenvironment induced by maraviroc as seen in the short-term explant models could also be observed in the patient biopsies. Marked reductions in key cytokines and growth factors promoting tumor growth, chemotherapy resistance, or angiogenesis were seen in most clinical samples



1566712434_marc.jpg



(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us